FormFactor, Inc. (NASDAQ:FORM – Get Free Report) was the recipient of a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 2,280,000 shares, a growth of 26.0% from the October 15th total of 1,810,000 shares. Based on an average trading volume of 602,700 shares, the short-interest ratio is currently 3.8 days. Currently, 3.0% of the shares of the company are sold short.
Wall Street Analyst Weigh In
A number of brokerages have issued reports on FORM. TD Cowen cut their target price on shares of FormFactor from $60.00 to $44.00 and set a “hold” rating on the stock in a report on Thursday, October 31st. StockNews.com lowered shares of FormFactor from a “buy” rating to a “hold” rating in a research note on Tuesday, August 27th. DA Davidson raised their price target on shares of FormFactor from $55.00 to $62.00 and gave the company a “buy” rating in a research note on Thursday, August 1st. Finally, Needham & Company LLC dropped their price target on shares of FormFactor from $60.00 to $52.00 and set a “buy” rating on the stock in a research note on Thursday, October 31st. Five analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, FormFactor currently has a consensus rating of “Hold” and an average price target of $55.38.
Get Our Latest Stock Analysis on FORM
FormFactor Price Performance
Insiders Place Their Bets
In other FormFactor news, CEO Mike Slessor sold 4,000 shares of the firm’s stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $45.28, for a total value of $181,120.00. Following the transaction, the chief executive officer now owns 530,276 shares of the company’s stock, valued at $24,010,897.28. This trade represents a 0.75 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 0.96% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in the business. Louisiana State Employees Retirement System grew its position in FormFactor by 0.5% in the second quarter. Louisiana State Employees Retirement System now owns 38,800 shares of the semiconductor company’s stock worth $2,349,000 after buying an additional 200 shares during the last quarter. Xponance Inc. grew its position in FormFactor by 5.1% in the second quarter. Xponance Inc. now owns 4,925 shares of the semiconductor company’s stock worth $298,000 after buying an additional 241 shares during the last quarter. Advisors Asset Management Inc. grew its position in FormFactor by 99.4% in the third quarter. Advisors Asset Management Inc. now owns 620 shares of the semiconductor company’s stock worth $29,000 after buying an additional 309 shares during the last quarter. Arizona State Retirement System grew its position in FormFactor by 1.5% in the second quarter. Arizona State Retirement System now owns 21,724 shares of the semiconductor company’s stock worth $1,315,000 after buying an additional 331 shares during the last quarter. Finally, CWM LLC boosted its stake in FormFactor by 25.5% in the 2nd quarter. CWM LLC now owns 1,823 shares of the semiconductor company’s stock worth $110,000 after purchasing an additional 370 shares during the period. Institutional investors and hedge funds own 98.76% of the company’s stock.
About FormFactor
FormFactor, Inc designs, manufactures, and sells probe cards, analytical probes, probe stations, metrology systems, thermal systems, and cryogenic systems to semiconductor companies and scientific institutions in the United States, Taiwan, South Korea, China, Europe, Japan, Malaysia, Singapore, and internationally.
See Also
- Five stocks we like better than FormFactor
- What Are Dividend Achievers? An Introduction
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Want to Profit on the Downtrend? Downtrends, Explained.
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Top Biotech Stocks: Exploring Innovation Opportunities
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for FormFactor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FormFactor and related companies with MarketBeat.com's FREE daily email newsletter.